Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma
Completed · Phase 2
Conditions studied: Relapsed or Refractory Large B-cell Lymphoma
In brief
The goal of this clinical study is to learn more about the study drug, axicabtagene ciloleucel, in participants with relapsed or refractory large B-cell lymphoma (LBCL) in the outpatient setting.
Key facts
- Study ID
- NCT05459571
- Run by
- Kite, A Gilead Company
- People needed
- 35
- Starts
- 2022-08-09
- Expected to finish
- 2025-11-24
- Last updated by the study team
- 2026-02-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center) — Duarte, California, United States
- UCLA — Los Angeles, California, United States
- Colorado Blood Cancer Institute — Denver, Colorado, United States
- University of Maryland Greenebaum Comprehensive Cancer Center — Baltimore, Maryland, United States
- Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
- John Theurer Cancer Center at Hackensack University Medical Center — Hackensack, New Jersey, United States
- Oncology Hematology Care Clinical Trials, LLC — Cincinnati, Ohio, United States
- Prisma Health - Upstate — Greenville, South Carolina, United States
- Tennessee Oncology, PLLC — Nashville, Tennessee, United States
- Henry-Joyce Cancer Clinic — Nashville, Tennessee, United States
- Methodist Healthcare System of San Antonio — San Antonio, Texas, United States
- Intermountain Healthcare — Murray, Utah, United States
- Huntsman Cancer Institute, University of Utah — Salt Lake City, Utah, United States
- University of Virginia Health System — Charlottesville, Virginia, United States
- Virginia Oncology Associates — Norfolk, Virginia, United States
- Virginia Commonwealth University — Richmond, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.